Last reviewed · How we verify
Theralite®
At a glance
| Generic name | Theralite® |
|---|---|
| Also known as | lithium carbonate |
| Sponsor | Centro de Atencion e Investigacion Medica |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Photodynamic Therapy in Non-surgical Periodontal Therapy (NA)
- The Effect of Photodynamic Therapy on Post-extraction Third Molar (NA)
- Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects (PHASE4)
- Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome (NA)
- Treatment of Young Permanent Teeth With Different Adjuvant Approaches (NA)
- Evaluation of Photodynamic Therapy in Treatment of Peri-implantitis (NA)
- Impact of Photodynamic Therapy as an Adjunct to Non-surgical Periodontal Treatment on Clinical and Biochemical Parameters Among Patients Having Mild Rheumatoid Arthritis With Periodontitis (NA)
- Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Theralite® CI brief — competitive landscape report
- Theralite® updates RSS · CI watch RSS
- Centro de Atencion e Investigacion Medica portfolio CI